The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 634.00
Bid: 632.00
Ask: 633.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.158%)
Open: 642.50
High: 642.50
Low: 630.00
Prev. Close: 634.00
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

26 Oct 2016 10:17

26 October 2016

Tate & Lyle PLC

Board changes

Tate & Lyle PLC (the “Company”) announces that Jeanne Johns has been appointed as a Non-Executive Director and a member of the Corporate Responsibility, Remuneration and Nominations Committees with effect from today, 26 October 2016.

Jeanne is based in the US and is a non-executive director of Parsons Corporation, a US engineering, construction, technical, and management services organisation. During Jeanne’s 30 year career with BP, she most recently served as the Head of Safety and Operational Risk for BP’s global downstream business from 2011 to 2015 and was responsible for overhauling the safety and operational risk organisation. Prior to this role, Jeanne held numerous leadership roles in Europe, the US and China, managing multinational businesses and global strategic business development.

Jeanne will assume the chairmanship of the Corporate Responsibility Committee with effect from 1 April 2017. She will replace Bill Camp who is retiring as a Director of the Company on 31 March 2017, having served on the Board since May 2010.

Sir Peter Gershon, Chairman of Tate & Lyle, said "I am delighted that Jeanne has agreed to join the Board. Her significant experience of building organisational cultures with the highest standards in safety, together with her experience in a range of global leadership roles will be of significant benefit to the Board.

“I would also like to thank Bill for his dedicated service and the significant contribution he has made to the Board and the Corporate Responsibility Committee during his tenure.”

There are no further disclosures to be made in connection with Ms Johns’s appointment pursuant to paragraph 9.6.13 of the Financial Conduct Authority’s Listing Rules.

For more information contact Tate & Lyle PLC:

Christopher Marsh, Group VP, Investor and Media Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688

Andrew Lorenz (FTI Consulting), Media Relations

Tel: +44 (0) 20 7269 7113 or Mobile: +44 (0) 7775 641 807

About Tate & Lyle:

Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, with operations at more than 25 facilities worldwide.

Tate & Lyle operates through two global divisions, Speciality Food Ingredients and Bulk Ingredients, supported by our Innovation and Commercial Development and Global Operations groups. The Group's strategy is to become a leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving Bulk Ingredients for sustained cash generation to fuel this growth.

Speciality Food Ingredients consists of three platforms: Texturants, which includes speciality starches and stabilisers; Sweeteners, which comprises nutritive sweeteners and our range of no-calorie sweeteners including SPLENDA® Sucralose; and our Health and Wellness portfolio which includes speciality fibres and our salt-reduction offering. Additionally, our Food Systems business provides a wide variety of blended ingredient solutions.

Tate & Lyle Bulk Ingredients includes bulk sweeteners, industrial starches and fermentation products (primarily acidulants). Corn co-products from both divisions are primarily sold as animal feed.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2016, Tate & Lyle sales totalled £2.4 billion. For more information, please visit http://www.tateandlyle.com.

SPLENDA® is a trademark of Heartland Consumer Products LLC.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161026005652/en/

Copyright Business Wire 2016

Date   Source Headline
5th Nov 20157:00 amBUSHalf-yearly Report
2nd Nov 20152:07 pmBUSTotal Voting Rights
2nd Nov 20151:22 pmBUSTate & Lyle Completes Re-Alignment of Eaststarch Joint Venture
8th Oct 20157:00 amBUSTrading Statement
29th Sep 20152:58 pmBUSJudgment re litigation
1st Sep 20159:59 amBUSTotal Voting Rights
25th Aug 20154:49 pmBUSDirector/PDMR Shareholding
4th Aug 20154:37 pmBUSDirector/PDMR Shareholding
30th Jul 20152:16 pmBUSDirector/PDMR Shareholding
29th Jul 20154:45 pmBUSResult of AGM
29th Jul 20157:00 amBUSTrading Statement
22nd Jul 201510:43 amBUSIssue of Debt
13th Jul 20154:52 pmBUSHolding(s) in Company
10th Jul 20154:34 pmBUSDirector/PDMR Shareholding
8th Jul 20152:52 pmBUSDirector/PDMR Shareholding
2nd Jul 201511:46 amBUSDirector/PDMR Shareholding
1st Jul 20152:42 pmBUSDirectorate Change
1st Jul 201510:09 amBUSBlocklisting Interim Review
1st Jul 20159:55 amBUSTotal Voting Rights
29th Jun 20154:51 pmBUSAnnual Financial Report
25th Jun 20151:57 pmBUSDirector/PDMR Shareholding
24th Jun 20156:16 pmBUSDirector/PDMR Shareholding
11th Jun 201510:33 amBUSDirector/PDMR Shareholding
10th Jun 201511:20 amBUSDirector/PDMR Shareholding
29th May 201510:03 amBUSDirector/PDMR Shareholding
28th May 20153:36 pmBUSDirector/PDMR Shareholding
28th May 20157:00 amBUSFinal Results
12th May 201510:30 amBUSHolding(s) in Company
1st May 201512:17 pmBUSTotal Voting Rights
21st Apr 201510:21 amBUSHolding(s) in Company
21st Apr 20157:00 amBUSTATE & LYLE ANNOUNCES MAJOR BUSINESS RE-ALIGNMENT TO FURTHER FOCUS ON AND STRENGTHEN SPECIALITY FOOD INGREDIENTS
10th Apr 201510:55 amBUSHolding(s) in Company
2nd Apr 20157:00 amBUSTrading Statement
1st Apr 20159:22 amBUSTotal Voting Rights
31st Mar 20156:21 pmBUSHolding(s) in Company
24th Mar 20154:47 pmBUSHolding(s) in Company
3rd Mar 20159:14 amBUSDirector Declaration
6th Feb 20157:00 amBUSTrading Statement
2nd Feb 20159:23 amBUSTotal Voting Rights
12th Jan 20153:32 pmBUSDirector/PDMR Shareholding
7th Jan 20152:32 pmBUSDirector/PDMR Shareholding
6th Jan 20159:04 amBUSDirector/PDMR Shareholding
2nd Jan 201511:24 amBUSBlocklisting Interim Review
2nd Jan 201511:00 amBUSTotal Voting Rights
19th Dec 20145:22 pmBUSTransaction in Own Shares
18th Dec 20145:13 pmBUSTransaction in Own Shares
17th Dec 20145:39 pmBUSTransaction in Own Shares
5th Dec 20145:26 pmBUSTransaction in Own Shares
5th Dec 20145:25 pmBUSHolding(s) in Company
5th Dec 201410:14 amBUSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.